Influence  ||| S:0 E:10 ||| NN
of  ||| S:10 E:13 ||| IN
enzymatic  ||| S:13 E:23 ||| JJ
hydrolyzate  ||| S:23 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
mussel  ||| S:38 E:45 ||| JJ
meat  ||| S:45 E:50 ||| NN
on  ||| S:50 E:53 ||| IN
growth  ||| S:53 E:60 ||| NN
and  ||| S:60 E:64 ||| CC
some  ||| S:64 E:69 ||| DT
indicators  ||| S:69 E:80 ||| NNS
of  ||| S:80 E:83 ||| IN
general  ||| S:83 E:91 ||| JJ
adaptation  ||| S:91 E:102 ||| NN
syndrome  ||| S:102 E:111 ||| NN
in  ||| S:111 E:114 ||| IN
rats  ||| S:114 E:119 ||| VBG
The  ||| S:119 E:123 ||| DT
impact  ||| S:123 E:130 ||| NN
of  ||| S:130 E:133 ||| IN
the  ||| S:133 E:137 ||| DT
15-day  ||| S:137 E:144 ||| JJ
consumption  ||| S:144 E:156 ||| NN
of  ||| S:156 E:159 ||| IN
enzymatic  ||| S:159 E:169 ||| JJ
hydrolyzate  ||| S:169 E:181 ||| NN
of  ||| S:181 E:184 ||| IN
the  ||| S:184 E:188 ||| DT
mussels  ||| S:188 E:196 ||| JJ
meat  ||| S:196 E:201 ||| NN
as  ||| S:201 E:204 ||| IN
a  ||| S:204 E:206 ||| DT
part  ||| S:206 E:211 ||| NN
of  ||| S:211 E:214 ||| IN
semi-synthetic  ||| S:214 E:229 ||| JJ
diet  ||| S:229 E:234 ||| NN
on  ||| S:234 E:237 ||| IN
some  ||| S:237 E:242 ||| DT
stress  ||| S:242 E:249 ||| NN
biomarkers  ||| S:249 E:260 ||| NNS
and  ||| S:260 E:264 ||| CC
apoptosis  ||| S:264 E:274 ||| JJ
activity  ||| S:274 E:283 ||| NN
in  ||| S:283 E:286 ||| IN
various  ||| S:286 E:294 ||| JJ
organs  ||| S:294 E:301 ||| NNS
of  ||| S:301 E:304 ||| IN
growing  ||| S:304 E:312 ||| VBG
male  ||| S:312 E:317 ||| JJ
Wistar  ||| S:317 E:324 ||| JJ
rats  ||| S:324 E:329 ||| NNS
have  ||| S:329 E:334 ||| VBP
been  ||| S:334 E:339 ||| VBN
studied ||| S:339 E:346 ||| VBN
.  ||| S:346 E:348 ||| .
Enzymatic  ||| S:348 E:358 ||| JJ
hydrolyzate  ||| S:358 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
the  ||| S:373 E:377 ||| DT
mussels  ||| S:377 E:385 ||| JJ
meat  ||| S:385 E:390 ||| NN
( ||| S:390 E:391 ||| -LRB-
EMM ||| S:391 E:394 ||| NNP
)  ||| S:394 E:396 ||| -RRB-
was  ||| S:396 E:400 ||| VBD
obtained  ||| S:400 E:409 ||| VBN
in  ||| S:409 E:412 ||| IN
pilot  ||| S:412 E:418 ||| NN
conditions  ||| S:418 E:429 ||| NNS
using  ||| S:429 E:435 ||| VBG
the  ||| S:435 E:439 ||| DT
enzyme  ||| S:439 E:446 ||| JJ
preparation  ||| S:446 E:458 ||| NN
Protozim ||| S:458 E:466 ||| NNP
.  ||| S:466 E:468 ||| .
The  ||| S:468 E:472 ||| DT
animals  ||| S:472 E:480 ||| NNS
of  ||| S:480 E:483 ||| IN
control  ||| S:483 E:491 ||| NN
group  ||| S:491 E:497 ||| NN
1  ||| S:497 E:499 ||| CD
( ||| S:499 E:500 ||| -LRB-
n  ||| S:500 E:502 ||| CD
=  ||| S:502 E:504 ||| SYM
8  ||| S:504 E:506 ||| CD
with  ||| S:506 E:511 ||| IN
initial  ||| S:511 E:519 ||| JJ
body  ||| S:519 E:524 ||| NN
weight  ||| S:524 E:531 ||| NN
of  ||| S:531 E:534 ||| IN
179.4  ||| S:534 E:540 ||| CD
±  ||| S:540 E:542 ||| CD
5.9  ||| S:542 E:546 ||| CD
g ||| S:546 E:547 ||| CD
)  ||| S:547 E:549 ||| -RRB-
and  ||| S:549 E:553 ||| CC
experimental  ||| S:553 E:566 ||| JJ
group  ||| S:566 E:572 ||| NN
2  ||| S:572 E:574 ||| CD
( ||| S:574 E:575 ||| -LRB-
n  ||| S:575 E:577 ||| CD
=  ||| S:577 E:579 ||| SYM
8 ||| S:579 E:580 ||| CD
,  ||| S:580 E:582 ||| ,
176.3  ||| S:582 E:588 ||| CD
±  ||| S:588 E:590 ||| CD
4.5  ||| S:590 E:594 ||| CD
g ||| S:594 E:595 ||| CD
)  ||| S:595 E:597 ||| -RRB-
received  ||| S:597 E:606 ||| VBD
a  ||| S:606 E:608 ||| DT
semi  ||| S:608 E:613 ||| JJ
synthetic  ||| S:613 E:623 ||| JJ
diet ||| S:623 E:627 ||| NN
;  ||| S:627 E:629 ||| :
the  ||| S:629 E:633 ||| DT
animals  ||| S:633 E:641 ||| NNS
of  ||| S:641 E:644 ||| IN
the  ||| S:644 E:648 ||| DT
experimental  ||| S:648 E:661 ||| JJ
group  ||| S:661 E:667 ||| NN
3  ||| S:667 E:669 ||| CD
( ||| S:669 E:670 ||| -LRB-
n  ||| S:670 E:672 ||| CD
=  ||| S:672 E:674 ||| SYM
8 ||| S:674 E:675 ||| CD
,  ||| S:675 E:677 ||| ,
177.6  ||| S:677 E:683 ||| CD
±  ||| S:683 E:685 ||| CD
4.0  ||| S:685 E:689 ||| CD
g ||| S:689 E:690 ||| CD
)  ||| S:690 E:692 ||| -RRB-
received  ||| S:692 E:701 ||| VBD
the  ||| S:701 E:705 ||| DT
same  ||| S:705 E:710 ||| JJ
semi  ||| S:710 E:715 ||| JJ
synthetic  ||| S:715 E:725 ||| JJ
diet  ||| S:725 E:730 ||| NN
in  ||| S:730 E:733 ||| IN
which  ||| S:733 E:739 ||| WDT
50 ||| S:739 E:741 ||| CD
%  ||| S:741 E:743 ||| NN
of  ||| S:743 E:746 ||| IN
the  ||| S:746 E:750 ||| DT
casein  ||| S:750 E:757 ||| NN
was  ||| S:757 E:761 ||| VBD
replaced  ||| S:761 E:770 ||| VBN
by  ||| S:770 E:773 ||| IN
the  ||| S:773 E:777 ||| DT
peptides  ||| S:777 E:786 ||| NN
of  ||| S:786 E:789 ||| IN
EMM ||| S:789 E:792 ||| NNP
.  ||| S:792 E:794 ||| .
On  ||| S:794 E:797 ||| IN
the  ||| S:797 E:801 ||| DT
penult  ||| S:801 E:808 ||| JJ
day  ||| S:808 E:812 ||| NN
of  ||| S:812 E:815 ||| IN
the  ||| S:815 E:819 ||| DT
experiment  ||| S:819 E:830 ||| NN
animals  ||| S:830 E:838 ||| NNS
of  ||| S:838 E:841 ||| IN
groups  ||| S:841 E:848 ||| NNS
2  ||| S:848 E:850 ||| CD
and  ||| S:850 E:854 ||| CC
3  ||| S:854 E:856 ||| CD
were  ||| S:856 E:861 ||| VBD
subjected  ||| S:861 E:871 ||| VBN
to  ||| S:871 E:874 ||| TO
stress  ||| S:874 E:881 ||| VB
exposure  ||| S:881 E:890 ||| NN
by  ||| S:890 E:893 ||| IN
electric  ||| S:893 E:902 ||| JJ
current  ||| S:902 E:910 ||| JJ
on  ||| S:910 E:913 ||| IN
their  ||| S:913 E:919 ||| PRP$
paws  ||| S:919 E:924 ||| NNS
( ||| S:924 E:925 ||| -LRB-
current  ||| S:925 E:933 ||| JJ
0.4  ||| S:933 E:937 ||| CD
mA  ||| S:937 E:940 ||| NN
for  ||| S:940 E:944 ||| IN
8  ||| S:944 E:946 ||| CD
seconds ||| S:946 E:953 ||| NNS
)  ||| S:953 E:955 ||| -RRB-
and  ||| S:955 E:959 ||| CC
were  ||| S:959 E:964 ||| VBD
placed  ||| S:964 E:971 ||| VBN
in  ||| S:971 E:974 ||| IN
metabolic  ||| S:974 E:984 ||| JJ
cages  ||| S:984 E:990 ||| NN
for  ||| S:990 E:994 ||| IN
the  ||| S:994 E:998 ||| DT
collection  ||| S:998 E:1009 ||| NN
of  ||| S:1009 E:1012 ||| IN
daily  ||| S:1012 E:1018 ||| JJ
urine ||| S:1018 E:1023 ||| NN
.  ||| S:1023 E:1025 ||| .
At  ||| S:1025 E:1028 ||| IN
the  ||| S:1028 E:1032 ||| DT
15th  ||| S:1032 E:1037 ||| JJ
day  ||| S:1037 E:1041 ||| NN
of  ||| S:1041 E:1044 ||| IN
the  ||| S:1044 E:1048 ||| DT
study ||| S:1048 E:1053 ||| NN
,  ||| S:1053 E:1055 ||| ,
all  ||| S:1055 E:1059 ||| DT
control  ||| S:1059 E:1067 ||| NN
and  ||| S:1067 E:1071 ||| CC
test  ||| S:1071 E:1076 ||| NN
animals  ||| S:1076 E:1084 ||| NNS
were  ||| S:1084 E:1089 ||| VBD
killed  ||| S:1089 E:1096 ||| VBN
by  ||| S:1096 E:1099 ||| IN
decapitation  ||| S:1099 E:1112 ||| NN
under  ||| S:1112 E:1118 ||| IN
ether  ||| S:1118 E:1124 ||| JJ
anesthesia  ||| S:1124 E:1135 ||| NN
and  ||| S:1135 E:1139 ||| CC
necropsied ||| S:1139 E:1149 ||| NN
.  ||| S:1149 E:1151 ||| .
The  ||| S:1151 E:1155 ||| DT
content  ||| S:1155 E:1163 ||| NN
of  ||| S:1163 E:1166 ||| IN
prostaglandin  ||| S:1166 E:1180 ||| JJ
E2  ||| S:1180 E:1183 ||| NN
and  ||| S:1183 E:1187 ||| CC
β-endorphin  ||| S:1187 E:1199 ||| JJ
in  ||| S:1199 E:1202 ||| IN
blood  ||| S:1202 E:1208 ||| NN
plasma  ||| S:1208 E:1215 ||| NN
was  ||| S:1215 E:1219 ||| VBD
determined  ||| S:1219 E:1230 ||| VBN
by  ||| S:1230 E:1233 ||| IN
ELISA  ||| S:1233 E:1239 ||| NNP
test ||| S:1239 E:1243 ||| NN
.  ||| S:1243 E:1245 ||| .
The  ||| S:1245 E:1249 ||| DT
concentration  ||| S:1249 E:1263 ||| NN
of  ||| S:1263 E:1266 ||| IN
urine  ||| S:1266 E:1272 ||| JJ
corticosterone  ||| S:1272 E:1287 ||| NN
was  ||| S:1287 E:1291 ||| VBD
measured  ||| S:1291 E:1300 ||| VBN
by  ||| S:1300 E:1303 ||| IN
HPLC ||| S:1303 E:1307 ||| NNP
.  ||| S:1307 E:1309 ||| .
DNA  ||| S:1309 E:1313 ||| NNP
damage  ||| S:1313 E:1320 ||| NN
and  ||| S:1320 E:1324 ||| CC
percentage  ||| S:1324 E:1335 ||| NN
of  ||| S:1335 E:1338 ||| IN
apoptotic  ||| S:1338 E:1348 ||| JJ
cells  ||| S:1348 E:1354 ||| NNS
( ||| S:1354 E:1355 ||| -LRB-
apoptotic  ||| S:1355 E:1365 ||| JJ
index ||| S:1365 E:1370 ||| NN
)  ||| S:1370 E:1372 ||| -RRB-
were  ||| S:1372 E:1377 ||| VBD
calculated  ||| S:1377 E:1388 ||| VBN
in  ||| S:1388 E:1391 ||| IN
thymus  ||| S:1391 E:1398 ||| NN
by  ||| S:1398 E:1401 ||| IN
single-cell  ||| S:1401 E:1413 ||| JJ
gel  ||| S:1413 E:1417 ||| FW
electrophoresis  ||| S:1417 E:1433 ||| FW
assay  ||| S:1433 E:1439 ||| FW
( ||| S:1439 E:1440 ||| -LRB-
Comet  ||| S:1440 E:1446 ||| UH
assay ||| S:1446 E:1451 ||| UH
) ||| S:1451 E:1452 ||| -RRB-
.  ||| S:1452 E:1454 ||| .
The  ||| S:1454 E:1458 ||| DT
relative  ||| S:1458 E:1467 ||| JJ
body  ||| S:1467 E:1472 ||| NN
weight  ||| S:1472 E:1479 ||| NN
increase  ||| S:1479 E:1488 ||| NN
of  ||| S:1488 E:1491 ||| IN
animals  ||| S:1491 E:1499 ||| NNS
treated  ||| S:1499 E:1507 ||| VBN
with  ||| S:1507 E:1512 ||| IN
EMM  ||| S:1512 E:1516 ||| NNP
was  ||| S:1516 E:1520 ||| VBD
significantly  ||| S:1520 E:1534 ||| RB
( ||| S:1534 E:1535 ||| -LRB-
p  ||| S:1535 E:1537 ||| CD
< ||| S:1537 E:1539 ||| SYM
0.05 ||| S:1539 E:1543 ||| CD
)  ||| S:1543 E:1545 ||| -RRB-
higher  ||| S:1545 E:1552 ||| JJR
( ||| S:1552 E:1553 ||| -LRB-
68.2  ||| S:1553 E:1558 ||| CD
±  ||| S:1558 E:1560 ||| CD
3.0 ||| S:1560 E:1563 ||| CD
% ||| S:1563 E:1564 ||| NN
)  ||| S:1564 E:1566 ||| -RRB-
than  ||| S:1566 E:1571 ||| IN
those  ||| S:1571 E:1577 ||| DT
in  ||| S:1577 E:1580 ||| IN
animals  ||| S:1580 E:1588 ||| NNS
of  ||| S:1588 E:1591 ||| IN
groups  ||| S:1591 E:1598 ||| NNS
1  ||| S:1598 E:1600 ||| CD
and  ||| S:1600 E:1604 ||| CC
2  ||| S:1604 E:1606 ||| CD
( ||| S:1606 E:1607 ||| -LRB-
57.2  ||| S:1607 E:1612 ||| CD
±  ||| S:1612 E:1614 ||| CD
4.0  ||| S:1614 E:1618 ||| CD
and  ||| S:1618 E:1622 ||| CC
59.7  ||| S:1622 E:1627 ||| CD
±  ||| S:1627 E:1629 ||| CD
2.8 ||| S:1629 E:1632 ||| CD
% ||| S:1632 E:1633 ||| NN
,  ||| S:1633 E:1635 ||| ,
respectively ||| S:1635 E:1647 ||| RB
) ||| S:1647 E:1648 ||| -RRB-
.  ||| S:1648 E:1650 ||| .
The  ||| S:1650 E:1654 ||| DT
apoptotic  ||| S:1654 E:1664 ||| JJ
index  ||| S:1664 E:1670 ||| NN
in  ||| S:1670 E:1673 ||| IN
thymus  ||| S:1673 E:1680 ||| JJ
cells  ||| S:1680 E:1686 ||| NNS
of  ||| S:1686 E:1689 ||| IN
tested  ||| S:1689 E:1696 ||| JJ
groups  ||| S:1696 E:1703 ||| NNS
of  ||| S:1703 E:1706 ||| IN
animals  ||| S:1706 E:1714 ||| NNS
( ||| S:1714 E:1715 ||| -LRB-
2  ||| S:1715 E:1717 ||| CD
and  ||| S:1717 E:1721 ||| CC
3 ||| S:1721 E:1722 ||| LS
)  ||| S:1722 E:1724 ||| -RRB-
was  ||| S:1724 E:1728 ||| VBD
significantly  ||| S:1728 E:1742 ||| RB
( ||| S:1742 E:1743 ||| -LRB-
p  ||| S:1743 E:1745 ||| CD
< ||| S:1745 E:1747 ||| SYM
0.05 ||| S:1747 E:1751 ||| CD
)  ||| S:1751 E:1753 ||| -RRB-
higher  ||| S:1753 E:1760 ||| JJR
( ||| S:1760 E:1761 ||| -LRB-
1.13  ||| S:1761 E:1766 ||| CD
±  ||| S:1766 E:1768 ||| CD
0.09  ||| S:1768 E:1773 ||| CD
and  ||| S:1773 E:1777 ||| CC
1.09  ||| S:1777 E:1782 ||| CD
±  ||| S:1782 E:1784 ||| CD
0.01 ||| S:1784 E:1788 ||| CD
% ||| S:1788 E:1789 ||| NN
)  ||| S:1789 E:1791 ||| -RRB-
compared  ||| S:1791 E:1800 ||| VBN
to  ||| S:1800 E:1803 ||| TO
intact  ||| S:1803 E:1810 ||| JJ
animals  ||| S:1810 E:1818 ||| NNS
of  ||| S:1818 E:1821 ||| IN
control  ||| S:1821 E:1829 ||| NN
group  ||| S:1829 E:1835 ||| NN
( ||| S:1835 E:1836 ||| -LRB-
1.04  ||| S:1836 E:1841 ||| CD
±  ||| S:1841 E:1843 ||| CD
0.01 ||| S:1843 E:1847 ||| CD
% ||| S:1847 E:1848 ||| NN
) ||| S:1848 E:1849 ||| -RRB-
.  ||| S:1849 E:1851 ||| .
Determination  ||| S:1851 E:1865 ||| NN
of  ||| S:1865 E:1868 ||| IN
β-endorphin  ||| S:1868 E:1880 ||| JJ
and  ||| S:1880 E:1884 ||| CC
prostaglandin  ||| S:1884 E:1898 ||| CD
E2  ||| S:1898 E:1901 ||| CD
levels  ||| S:1901 E:1908 ||| NNS
did  ||| S:1908 E:1912 ||| VBD
not  ||| S:1912 E:1916 ||| RB
shown  ||| S:1916 E:1922 ||| VBN
any  ||| S:1922 E:1926 ||| DT
significant  ||| S:1926 E:1938 ||| JJ
differences  ||| S:1938 E:1950 ||| NNS
between  ||| S:1950 E:1958 ||| IN
the  ||| S:1958 E:1962 ||| DT
groups ||| S:1962 E:1968 ||| NNS
.  ||| S:1968 E:1970 ||| .
Significantly  ||| S:1970 E:1984 ||| RB
( ||| S:1984 E:1985 ||| -LRB-
p  ||| S:1985 E:1987 ||| CD
< ||| S:1987 E:1989 ||| SYM
0.05 ||| S:1989 E:1993 ||| CD
)  ||| S:1993 E:1995 ||| -RRB-
lower  ||| S:1995 E:2001 ||| JJR
concentrations  ||| S:2001 E:2016 ||| NNS
of  ||| S:2016 E:2019 ||| IN
corticosterone  ||| S:2019 E:2034 ||| NN
was  ||| S:2034 E:2038 ||| VBD
found  ||| S:2038 E:2044 ||| VBN
in  ||| S:2044 E:2047 ||| IN
the  ||| S:2047 E:2051 ||| DT
daily  ||| S:2051 E:2057 ||| JJ
urine  ||| S:2057 E:2063 ||| NN
of  ||| S:2063 E:2066 ||| IN
stressed  ||| S:2066 E:2075 ||| JJ
animals  ||| S:2075 E:2083 ||| NNS
from  ||| S:2083 E:2088 ||| IN
group  ||| S:2088 E:2094 ||| NN
3  ||| S:2094 E:2096 ||| CD
( ||| S:2096 E:2097 ||| -LRB-
452  ||| S:2097 E:2101 ||| CD
±  ||| S:2101 E:2103 ||| CD
78  ||| S:2103 E:2106 ||| CD
ng ||| S:2106 E:2108 ||| CD
/ ||| S:2108 E:2109 ||| CD
ml ||| S:2109 E:2111 ||| CD
) ||| S:2111 E:2112 ||| -RRB-
,  ||| S:2112 E:2114 ||| ,
treated  ||| S:2114 E:2122 ||| VBN
with  ||| S:2122 E:2127 ||| IN
EMM ||| S:2127 E:2130 ||| NNP
,  ||| S:2130 E:2132 ||| ,
compared  ||| S:2132 E:2141 ||| VBN
to  ||| S:2141 E:2144 ||| TO
stressed  ||| S:2144 E:2153 ||| VB
animals  ||| S:2153 E:2161 ||| NNS
of  ||| S:2161 E:2164 ||| IN
group  ||| S:2164 E:2170 ||| NN
2  ||| S:2170 E:2172 ||| ,
that  ||| S:2172 E:2177 ||| WDT
received  ||| S:2177 E:2186 ||| VBD
a  ||| S:2186 E:2188 ||| DT
casein  ||| S:2188 E:2195 ||| JJ
diet  ||| S:2195 E:2200 ||| NN
( ||| S:2200 E:2201 ||| -LRB-
834  ||| S:2201 E:2205 ||| CD
±  ||| S:2205 E:2207 ||| CD
167  ||| S:2207 E:2211 ||| CD
ng ||| S:2211 E:2213 ||| CD
/ ||| S:2213 E:2214 ||| CD
ml ||| S:2214 E:2216 ||| CD
) ||| S:2216 E:2217 ||| -RRB-
.  ||| S:2217 E:2219 ||| .
It  ||| S:2219 E:2222 ||| PRP
has  ||| S:2222 E:2226 ||| VBZ
been  ||| S:2226 E:2231 ||| VBN
shown  ||| S:2231 E:2237 ||| VBN
that  ||| S:2237 E:2242 ||| IN
consumption  ||| S:2242 E:2254 ||| NN
of  ||| S:2254 E:2257 ||| IN
EMM  ||| S:2257 E:2261 ||| NNP
with  ||| S:2261 E:2266 ||| IN
a  ||| S:2266 E:2268 ||| DT
high  ||| S:2268 E:2273 ||| JJ
content  ||| S:2273 E:2281 ||| NN
of  ||| S:2281 E:2284 ||| IN
short  ||| S:2284 E:2290 ||| JJ
and  ||| S:2290 E:2294 ||| CC
medium  ||| S:2294 E:2301 ||| JJ
peptides  ||| S:2301 E:2310 ||| NN
has  ||| S:2310 E:2314 ||| VBZ
an  ||| S:2314 E:2317 ||| DT
impact  ||| S:2317 E:2324 ||| NN
on  ||| S:2324 E:2327 ||| IN
effectiveness  ||| S:2327 E:2341 ||| NN
of  ||| S:2341 E:2344 ||| IN
body  ||| S:2344 E:2349 ||| NN
weight  ||| S:2349 E:2356 ||| NN
gain  ||| S:2356 E:2361 ||| NN
of  ||| S:2361 E:2364 ||| IN
growing  ||| S:2364 E:2372 ||| VBG
laboratory  ||| S:2372 E:2383 ||| NN
animals ||| S:2383 E:2390 ||| NNS
,  ||| S:2390 E:2392 ||| ,
and  ||| S:2392 E:2396 ||| CC
restrict  ||| S:2396 E:2405 ||| VB
the  ||| S:2405 E:2409 ||| DT
increase  ||| S:2409 E:2418 ||| NN
of  ||| S:2418 E:2421 ||| IN
corticosterone  ||| S:2421 E:2436 ||| JJ
level  ||| S:2436 E:2442 ||| NN
in  ||| S:2442 E:2445 ||| IN
rats  ||| S:2445 E:2450 ||| JJ
blood ||| S:2450 E:2455 ||| NN
,  ||| S:2455 E:2457 ||| ,
which  ||| S:2457 E:2463 ||| WDT
is  ||| S:2463 E:2466 ||| VBZ
typical  ||| S:2466 E:2474 ||| JJ
for  ||| S:2474 E:2478 ||| IN
general  ||| S:2478 E:2486 ||| JJ
adaptation  ||| S:2486 E:2497 ||| NN
syndrome ||| S:2497 E:2505 ||| NN
.  ||| S:2505 E:2507 ||| .
